Cargando…
Covid-19 Impfungen – Impfstofftechnologien
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215092/ https://www.ncbi.nlm.nih.gov/pubmed/34176964 http://dx.doi.org/10.1007/s00608-021-00893-7 |
| _version_ | 1783710176260390912 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8215092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Vienna |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82150922021-06-21 Covid-19 Impfungen – Impfstofftechnologien Padiatr Padol Interview Springer Vienna 2021-06-21 2021 /pmc/articles/PMC8215092/ /pubmed/34176964 http://dx.doi.org/10.1007/s00608-021-00893-7 Text en © Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Interview Covid-19 Impfungen – Impfstofftechnologien |
| title | Covid-19 Impfungen – Impfstofftechnologien |
| title_full | Covid-19 Impfungen – Impfstofftechnologien |
| title_fullStr | Covid-19 Impfungen – Impfstofftechnologien |
| title_full_unstemmed | Covid-19 Impfungen – Impfstofftechnologien |
| title_short | Covid-19 Impfungen – Impfstofftechnologien |
| title_sort | covid-19 impfungen – impfstofftechnologien |
| topic | Interview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215092/ https://www.ncbi.nlm.nih.gov/pubmed/34176964 http://dx.doi.org/10.1007/s00608-021-00893-7 |